Newsroom | 5559 results

LUGANO, Switzerland--(BUSINESS WIRE)--SFI Health reports publication of the results from a study about the impact of Long-Chain Polyunsaturated Fatty Acids on literacy skills in children....

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product candidates called pherines, presented exploratory data at The Menopause Society 2025 Annual Meeting in Orlando, Florida. These findings demonstrate PH80’s potential as a rapidly-acting pherine product candidate for treating vasomotor symptoms (hot flashes) du...

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce that James Yamanaka, formerly Global Head of Strategy for British American Tobacco, has been appointed the Company’s new Chief Executive Officer (CEO). Mr. Yamanaka is expected to assume the role effective on or about January 15, 2026. Mr. Yamanaka will also join the Company's board of di...

PORTLAND, Ore.--(BUSINESS WIRE)--A new pilot study from Experience Onward, one of the first licensed psilocybin treatment centers in the United States, shows promising evidence that psilocybin may improve brain function and psychological well-being in athletes living with long-term concussion symptoms. Self-funded in partnership with Athletes Journey Home and facilitated by Onaya Science, the project provides an early look at emerging pathways for supporting concussion and traumatic brain injur...

MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Piper Sandler 37th Annual Healthcare Conference. AtriCure’s management is scheduled to participate in a fireside discussion on Tuesday, December 2, 2025, at 10:00 a.m. Eastern Standard Time. Interested...

BOSTON--(BUSINESS WIRE)--EO Care, Inc., the leader in cannabinoid-based symptom management, released data using PROMIS* measures showing that patients leveraging its guided cannabinoid products and care platform reported meaningful improvements for pain, sleep, anxiety, and nausea/vomiting**. Meaningful improvements were reported by patients after one (1) week and sustained through four (4) weeks of guided cannabinoid care, particularly among people over 50 and cancer patients. Patients also re...

WASHINGTON--(BUSINESS WIRE)--The U.S. Hemp Roundtable, the leading voice for robust hemp regulation to protect consumers and the industry, recapped for its members recent legislation that negatively impacts the industry and touted hope for the future. Despite the legislation, the group says they are positioned to spend the next year advocating for the industry – 365 days to regulate, not ban. Below is a summary of the update shared with Roundtable members: The bill to reopen the government incl...

AUSTIN, Texas & EINDHOVEN, Niederlande--(BUSINESS WIRE)--Fluence, ein weltweit führender Anbieter von energieeffizienten LED-Beleuchtungslösungen für die kommerzielle Cannabisproduktion, wird auf der MJBizCon 2025 in Las Vegas seine neueste Innovation im Bereich Gartenbau vorstellen: das Red Sandwich. Die Besucher können es zusammen mit den neuesten Leuchten von Fluence, darunter RAPTR 2, PYTHN, SPYDR 3 und VYPR 4, am Stand Nr. 15023 besichtigen. Red Sandwich, das sich derzeit im Patentverfahre...

AUSTIN, Texas e EINDHOVEN, Países Baixos--(BUSINESS WIRE)--A Fluence, um fornecedor global líder em soluções de iluminação LED energeticamente eficientes para a produção comercial de canábis, irá revelar a sua mais recente inovação hortícola - Red Sandwich - na MJBizCon 2025 em Las Vegas. Os participantes poderão ver este produto juntamente com as lâmpadas mais recentes da Fluence, incluindo RAPTR 2, PYTHN, SPYDR 3 e VYPR 4, no Stand n.º 15023. Desenvolvido ao longo de anos de investigação sobr...

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Serenity Mental Health Centers, a leader in innovative psychiatric care and one of the fastest-growing mental health providers in the nation, today announced the availability of non-medication mental health treatments at its Colorado Springs clinic. With rates of depression and anxiety continuing to rise nationwide, patients are increasingly searching for effective alternatives to prescription medications. Serenity’s board-certified psychiatrists and ps...